Recent solubility and dissolution enhancement techniques for repaglinide a BCS class II drug: a review
Repaglinide is an oral blood-glucose-lowering drug used to manage type-2 diabetes mellitus by lowering post-prandial glucose by stimulating insulin secretion from pancreatic beta cells. According to the biopharmaceutical classification system, repaglinide falls under the class II category. Fo...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pensoft Publishers
2021-08-01
|
| Series: | Pharmacia |
| Online Access: | https://pharmacia.pensoft.net/article/66586/download/pdf/ |